Related references
Note: Only part of the references are listed.The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges
Andreea Milan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Different Roles of Beclin 1 in the Interaction Between Glia and Neurons after Exposure to Morphine and the HIV- Trans-Activator of Transcription (Tat) Protein
Jessica Lapierre et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2022)
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives
Peng Liu et al.
MOLECULES (2022)
Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases
Yuan Jiang et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Sonalika Bhalla et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)
αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma
Yongwei Gu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Redox-sensitive polymeric micelles with aggregation-induced emission for bioimaging and delivery of anticancer drugs
Changzhen Sun et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Impaired autophagy: The collateral damage of lysosomal storage disorders
Rachel Myerowitz et al.
EBIOMEDICINE (2021)
Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression
Miriam S. Domowicz et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis
Maria Gutierrez-Fernandez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Lipid Nanoparticles Loaded with Iridoid Glycosides: Development and Optimization Using Experimental Factorial Design
Marta Dabrowska et al.
MOLECULES (2021)
Extracellular Vesicles as Drug Delivery System for the Treatment of Neurodegenerative Disorders: Optimization of the Cell Source
Matthew J. Haney et al.
ADVANCED NANOBIOMED RESEARCH (2021)
Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy
Matthew J. Haney et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
Lipid-based nanoformulations in the treatment of neurological disorders
Faheem Hyder Pottoo et al.
DRUG METABOLISM REVIEWS (2020)
Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes
Matthew J. Haney et al.
CELLS (2020)
TPP1 Delivery to Lysosomes with Extracellular Vesicles and their Enhanced Brain Distribution in the Animal Model of Batten Disease
Matthew J. Haney et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine
Francis Man et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract
Camille Dumont et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Microtubule-Asssociated Proteins: Structuring the Cytoskeleton
Satish Bodakuntla et al.
TRENDS IN CELL BIOLOGY (2019)
Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses
Anil B. Mukherjee et al.
MOLECULAR NEURODEGENERATION (2019)
Gold nanoparticle based fluorescent oligonucleotide probes for imaging and therapy in living systems
Yanjing Yang et al.
ANALYST (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review
A. Garces et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Study of Intraventricular Cerliponase Alfa for CLN2 Disease
Angela Schulz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells
Liya Zhu et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Nanoparticle-Laden Macrophages for Tumor-Tropic Drug Delivery
Weizhong Zhang et al.
ADVANCED MATERIALS (2018)
Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Abhirup Mandal et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Dongfen Yuan et al.
BIOMATERIALS (2017)
Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease
Rebecca E. H. Whiting et al.
EXPERIMENTAL EYE RESEARCH (2016)
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Matthew J. Haney et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Elena V. Batrakova et al.
JOURNAL OF CONTROLLED RELEASE (2015)
AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease
Martin L. Katz et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe et al.
FRONTIERS IN PHARMACOLOGY (2015)
An Overview of Autophagy: Morphology, Mechanism, and Regulation
Katherine R. Parzych et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins
Natalia L. Klyachko et al.
NANOMEDICINE (2014)
Brain tumor-targeted drug delivery strategies
Xiaoli Wei et al.
ACTA PHARMACEUTICA SINICA B (2014)
Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
Su Chul Jang et al.
ACS NANO (2013)
Human pathology in NCL
Glenn W. Anderson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Exosomes for drug delivery - a novel application for the mesenchymal stem cell
Ruenn Chai Lai et al.
BIOTECHNOLOGY ADVANCES (2013)
Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis
Janos Groh et al.
BRAIN (2013)
Autophagy in lysosomal storage disorders
Andrew P. Lieberman et al.
AUTOPHAGY (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery
Matthew J. Haney et al.
NANOMEDICINE (2012)
p62/SQSTM1/A170: Physiology and pathology
Masaaki Komatsu et al.
PHARMACOLOGICAL RESEARCH (2012)
Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses
R. Kohan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain
Xiaoying Zhuang et al.
MOLECULAR THERAPY (2011)
Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease
E. N. Mangano et al.
NEUROBIOLOGY OF DISEASE (2011)
Improved method for combination of immunocytochemistry and Nissl staining
Andrea Kadar et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
Michael Chang et al.
MOLECULAR THERAPY (2008)
A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF)
Wolf-Ruediger Schaebitz et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy
Serhiy Pankiv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector
Dolan Sondhi et al.
MOLECULAR THERAPY (2007)
Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease)
M Koike et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death
G Bjorkoy et al.
JOURNAL OF CELL BIOLOGY (2005)
Role of insulin-like growth factor I signaling in neurodegenerative diseases
JL Trejo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration
DE Sleat et al.
JOURNAL OF NEUROSCIENCE (2004)
Effects of block length and structure of surfactant on self-assembly and solution behavior of block ionomer complexes
TK Bronich et al.
LANGMUIR (2000)